Autori: Szer Jeffrey
| Naslov | Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study (Article) |
| Autori | Patriquin Christopher J Bogdanovic Andrija D Griffin Morag Kelly Richard J Maciejewski Jaroslaw P Mulherin Brian De Latour Regis Peffault Roeth Alexander Selvaratnam Veena Szer Jeffrey Al Adhami Mohammed Horneff Regina Tan Lisa Yeh Michael Panse Jens |
| Info | ADVANCES IN THERAPY, (2024), vol. 41 br. 5, str. 2050-2069 |
| Projekat | Apellis Pharmaceuticals |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
| Naslov | Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase (Article) |
| Autori | Pastores Gregory M Shankar Suma P Petakov Milan S Giraldo Pilar Rosenbaum Hanna Amato Dominick J Szer Jeffrey Chertkoff Raul Brill-Almon Einat Zimran Ari |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 661-665 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase (Article) |
| Autori | Pastores Gregory M Petakov Milan S Giraldo Pilar Rosenbaum Hanna Szer Jeffrey Deegan Patrick B Amato Dominick J Mengel Eugen Tan Ee Shien Chertkoff Raul Brill-Almon Einat Zimran Ari |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2014), vol. 53 br. 4, str. 253-260 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
